Braeburn is a pharmaceutical company dedicated to addressing the challenges associated with opioid use disorder (OUD). The organization focuses on delivering innovative treatment solutions that support individuals affected by OUD, aiming to transform care and ensure that patients receive optimal support for their recovery journey. Braeburn partners with healthcare providers and community organizations to foster a more effective management and treatment approach for OUD. The company values authenticity, collaboration, and empowerment, striving to create an inclusive culture where all voices are heard and all employees can contribute to its mission. By emphasizing shared commitment and innovation, Braeburn seeks to make a meaningful impact on the lives of those grappling with the complexities of opioid addiction.